INTERNATIONAL PATENT: ARCUS BIOSCIENCES, INC. FILES APPLICATION FOR "CASDATIFAN FOR USE IN THE TREATMENT OF CANCER"

GENEVA, Nov. 18 -- ARCUS BIOSCIENCES, INC. (c/o Arcus Biosciences, Inc.3928 Point Eden WayHayward, California 94545) filed a patent application (PCT/US2025/027965) for "CASDATIFAN FOR USE IN THE TREATMENT OF CANCER" on May 06, 2025. With publication no. WO/2025/235493, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AGORAM, Balaji (c/o Arcus Biosciences, Inc.3928 Point Eden WayHayward, California 94545), FOSTER, Paul G. (c/o Arcus Biosciences, Inc.3928 Point Eden WayHayward, California 94545), GHASEMI, Mohammad (c/o Arcus...